.png){kind=logo}
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Nov 18, 2024With its Meal Detection Technology™* and autocorrections every 5 minutes, Medtronic is expanding outcomes to populations in Asia and empowering patients to achieve greater glycemic control, especially during mealtimes.Medtronic, a global leader in healthcare technology, today shared new clinical and real-world evidence on the MiniMed™ 780G system from the Asia Pacific region demonstrating its ability to...
- Nov 7, 2024New data from Australia, Japan, India, Singapore, Hong Kong, and South Korea demonstrates the MiniMed™ 780G is driving consistent clinical outcomes in diabetes management.
Medtronic plc, a global leader in medical technology, announced new clinical and real-world data to be presented at the inaugural Asian Conference on Innovative Therapies for Diabetes Management...
Oct 4, 2024Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issueMedtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700...
- Sep 4, 2024The company will present clinical evidence in young children, pregnancy and type 2 diabetes*
Medtronic plc, the global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming European Association for the Study of Diabetes (EASD) 60th...
- Aug 7, 2024Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) —...
- Jun 21, 2024With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that...
Jun 4, 2024Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technologyMedtronic, a global leader in healthcare technology, today announced that Dr. Goran Petrovski M.D., Ph.D. has joined the company’s Diabetes Operating Unit as Medical Affairs Director. Dr....
- Jun 3, 2024
Medtronic, a global leader in medical technology, today announced an overview of its upcoming presence at the American Diabetes Association's (ADA) 84th Scientific Sessions. Following the one-year...
- Apr 30, 2024Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy.
Medtronic, a global leader in healthcare technology, today announced the results of the randomized controlled Closed- loop insulin delivery in pregnant women with type 1 diabetes: a randomized...
- Apr 23, 2024Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems.
Medtronic, a global leader in healthcare technology, shared results from separate studies highlighting that the Medtronic MiniMed™ 780G system is a cost-effective therapy option for people...